CVRx
CVRx

CVRx

Health Care Equipment & Supplies
WebsiteInvestor RelationsSEC
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

$34.6M

Market Cap • 10/16/2026

2000

(26 years)

Founded

2021

(5 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

130,2

P/S

0,6

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

—

EPS

—

Market Cap

Market Cap

34,6M

EV

93,7M

EV/Revenue

1,5

EV/EBITDA

-2

EV/EBIT

-1,9

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-5%

Total Yield

-5%

Payout

0%

Profitability

Gross Margin

86,9%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

20,2%

Capex/Revenue

1%

Capex/D&A

75,3%

Capex/OCF

-1,5%

SBC/OCF

—

% PPE

3%

% Goodwill

0%

ROE

—

ROIC

—

Growth

CAGR Revenue 5Y

46,5%

CAGR Op. Income 5Y

26,4%

CAGR Net Income 5Y

9,5%

CAGR EPS 5Y

-53,6%

CAGR OCF 5Y

14,3%

Leverage

N.D./EBITDA

—

Debt/Equity

0%

Current Ratio

0

Quick Ratio

0

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium